// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























914 Abstracts

MOLECULAR MECHANISMS OF FIBROGENESIS IN PULMONARY FIBROSIS

O. Eickelberg - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

CCL18 A POTENTIAL BIOMARKER OF FIBRO-INFLAMMATORY ACTIVITY IN CHRONIC PERIAORTITIS

F. Kollert - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

DEVELOPING A DISEASE ACTIVITY AND THERAPEUTIC RESPONSE INDEX IN CONNECTIVE TISSUE DISEASE - INTERSTITIAL LUNG DISEASE (CTD-ILD): RESULTS FROM A DELPHI EXERCISE: CONSENSUS ON DOMAINS

L.A. Saketkoo - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

HISTOPATHOLOGY OF ILD IN RHEUMATIC DISEASE - WHAT CLUES DOES IT PROVIDE RE PATHOGENESIS AND TREATMENT OPTIONS

A. Wells - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

INTERSTITIAL PNEUMONITIS ASSOCIATED WITH RHEUMATOID ARTHRITIS IS MORE PREVALENT IN AGED MALE WITH A HIGHER RF LEVEL, AND FREQUENTLY COMBINED WITH EMPHYSEMA

E. Matsubara - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

PULMONARY FIBROSIS AND CONNECTIVE TISSUE DISEASES: FOLLOW-UP OF LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS

A. Soriano - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

SAFETY AND CLINICAL RESPONSE TO RITUXIMAB IN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE: PRELIMINARY RESULTS

F.I. Romero - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

Rituximab

THE DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF ANTI-MDA5 ANTIBODY IN DERMATOMYOSITIS COMPLICATED INTERSTITIAL LUNG DISEASE IN CHINESE

Z. Chen - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

N/A

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF INTERSTITIAL LUNG DISEASE IN JAPANESE PATIENTS WITH MICROSCOPIC POLYANGIITIS

A. Maeda - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Cyclophosphamide

Lung Transplantation in Rheumatoid Arthritis Compared with Idiopathic Pulmonary Fibrosis and Scleroderma

Lianne Singer - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

Is Idiopathic Pulmonary Fibrosis Really Idiopathic?: Patterns of Reflux Analyzed by Bi-Positional High-Resolution Manometry and Hypopharyngeal Multichannel Intraluminal Impedance

Yoshihiro Komatsu - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Idiopathic pulmonary fibrosis

N/A

Impedance-pH Explores With More Accuracy Than pH-Metry Alone the Relationship Between Aspiration of Gastric Contents and Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis

Patrizia Zentilin - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Idiopathic pulmonary fibrosis

N/A

Pre-Transplant Proton Pump Inhibitor Is Not Associated With Improved Survival of Lung Allografts

Kongkiat Chaikriangkrai - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Idiopathic pulmonary fibrosis

N/A

Idiopathic Pulmonary Fibrosis Is Associated With Increased Impedance Measures of Reflux Compared to Non-Fibrotic Disease Among Pre-Lung Transplant Patients

Raymond T. Finn - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Idiopathic pulmonary fibrosis

N/A

Constitutional Telomerase-Associated Gene Variants in Pediatric Acute Myeloid Leukemia (AML)

M. Monica Gramatges - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Idiopathic pulmonary fibrosis

N/A

Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients a Shift Lo Late Onset Disease

Eli Muchtar - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Rituximab

Post Operative Outcomes After Cardiac Surgery in Patients With Interstitial Lung Disease

Gary M. Hunninghake - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Idiopathic pulmonary fibrosis

N/A

Endothelin Converting Enzyme-1 (ECE1) is Essential in Adult Normal Physiology

Michael Johnson - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Idiopathic pulmonary fibrosis

Tamoxifen

Non-invasive Screening for Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis

Mostafa Ahmed - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Idiopathic pulmonary fibrosis

N/A

Metabolic Modulation of the Diseased Human Lung; A Translational, Novel ex vivo Lung Perfusion Model

Adam Kinnaird - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Idiopathic pulmonary fibrosis

4-phenylbutyrate

Copyright © 2026. QuantiNova All rights reserved